256 related articles for article (PubMed ID: 1866200)
21. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
22. Ringed sideroblasts in primary myelodysplasia. Leukemic propensity and prognostic factors.
Vandermolen L; Rice L; Rose MA; Lynch EC
Arch Intern Med; 1988 Mar; 148(3):653-6. PubMed ID: 3341866
[TBL] [Abstract][Full Text] [Related]
23. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
24. [Prognostic potential of morphological and cytogenetic indices in patients with myelodysplastic syndrome].
Gritsaev SV; Martynkevich IS; Abdulkadyrov KM; Tiranova SA; Kakaĭ MP; Martynenko LS; Dziavgo LA
Ter Arkh; 2005; 77(7):22-7. PubMed ID: 16116904
[TBL] [Abstract][Full Text] [Related]
25. Effect of thrombopoietin on proliferation of blasts from patients with myelodysplastic syndromes.
Luo SS; Ogata K; Yokose N; Kato T; Dan K
Stem Cells; 2000; 18(2):112-9. PubMed ID: 10742383
[TBL] [Abstract][Full Text] [Related]
26. In vivo measurements of the T1 relaxation processes in the bone marrow in patients with myelodysplastic syndrome. A magnetic resonance imaging study.
Jensen KE; Nielsen H; Thomsen C; Sørensen PG; Karle H; Christoffersen P; Henriksen O
Acta Radiol; 1989; 30(4):365-8. PubMed ID: 2775597
[TBL] [Abstract][Full Text] [Related]
27. [Myelodysplastic syndrome--its natural history, clinical course and diagnosis].
Weryńska B
Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):867-71. PubMed ID: 2487939
[No Abstract] [Full Text] [Related]
28. [Preliminary study of biological characteristics of myelodysplastic syndromes clonal cells].
Li X; Wu LY; Ying SX; Chang CK; He Q; Song LQ; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):478-83. PubMed ID: 18072633
[TBL] [Abstract][Full Text] [Related]
29. Expression dynamics of drug resistance genes, multidrug resistance 1 (MDR1) and lung resistance protein (LRP) during the evolution of overt leukemia in myelodysplastic syndromes.
Kurata M; Hasegawa M; Nakagawa Y; Abe S; Yamamoto K; Suzuki K; Kitagawa M
Exp Mol Pathol; 2006 Dec; 81(3):249-54. PubMed ID: 16566920
[TBL] [Abstract][Full Text] [Related]
30. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome.
Schlesinger M; Silverman LR; Jiang JD; Yagi MJ; Holland JF; Bekesi JG
J Clin Lab Immunol; 1996; 48(4):149-66. PubMed ID: 9819667
[TBL] [Abstract][Full Text] [Related]
31. [Histopathologic diagnosis of bone marrow in leukemia and related disorders].
Kikuchi M; Ohshima K; Kobari S
Rinsho Byori; 1991 Dec; 39(12):1245-9. PubMed ID: 1779461
[TBL] [Abstract][Full Text] [Related]
32. CD34 immunohistochemical staining of bone marrow biopsies in myelodysplastic syndromes.
Min YH; Lee ST; Min DW; Kim TS; Lee CH; Lee BK; Hahn JS; Ko YW
Yonsei Med J; 1995 Mar; 36(1):1-8. PubMed ID: 7537931
[TBL] [Abstract][Full Text] [Related]
33. [Role of hemopoietic stem cells and progenitor cells in preleukemia].
Dörmer P; Mergenthaler HG
Verh Dtsch Ges Pathol; 1990; 74():65-74. PubMed ID: 1708637
[TBL] [Abstract][Full Text] [Related]
34. [Overt leukemia from MDS associated with marked basophilia].
Shirakawa C; Ohno M; Sugishima H; Morita S; Masaki H; Fujimoto T; Maeda Y; Irimajiri K; Horiuchi A
Rinsho Ketsueki; 1992 Aug; 33(8):1031-5. PubMed ID: 1404858
[TBL] [Abstract][Full Text] [Related]
35. Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS).
Kotsianidis I; Bouchliou I; Nakou E; Spanoudakis E; Margaritis D; Christophoridou AV; Anastasiades A; Tsigalou C; Bourikas G; Karadimitris A; Tsatalas C
Leukemia; 2009 Mar; 23(3):510-8. PubMed ID: 19020538
[TBL] [Abstract][Full Text] [Related]
36. [MR imaging findings of the femoral marrow in myelodysplastic syndrome].
Tanaka O; Takagi S; Matsuura K; Ichikawa T; Kobayashi Y; Nagai J
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Oct; 55(12):837-44. PubMed ID: 8539101
[TBL] [Abstract][Full Text] [Related]
37. The histological characterization of ALIP in the myelodysplastic syndromes.
De Wolf-Peeters C; Stessens R; Desmet V; Tricot G; Verwilghen RL
Pathol Res Pract; 1986 Aug; 181(4):402-7. PubMed ID: 3763479
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical evaluation of bone marrow biopsies in myelodysplastic syndromes.
Soligo D; Luksch R; Quirici N; Foa P; Moneta D; Somalvico F; Lambertenghi Deliliers G
Haematologia (Budap); 1991; 24(1):39-46. PubMed ID: 1813362
[TBL] [Abstract][Full Text] [Related]
39. Significance of fetal hemoglobin-containing erythroblasts (F blasts) and the F blast/F cell ratio in myelodysplastic syndromes.
Choi JW; Kim Y; Fujino M; Ito M
Leukemia; 2002 Aug; 16(8):1478-83. PubMed ID: 12145688
[TBL] [Abstract][Full Text] [Related]
40. The parameters of cellular proliferation in acute (immature-cell) leukemias.
Urasiński I; Kordecki H
Pol Med Sci Hist Bull (1973); 1976; 15(3):305-10. PubMed ID: 995767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
